Key Dates

Related Announcements

PAR-20-310 - Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)

Issued by

National Eye Institute (NEI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Eye Institute (NEI) will participate in Funding Opportunity Announcement (FOA) PAR-20-310, "Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional)", beginning with the March 17, 2022 due date and subsequent due dates.

The following section of the FOA has been changed to add the NEI specific clinical trial information (changes shown in bold italics):

Part 1. Overview Information
Components of Participating Organizations

National Institute on Minority Health and Health Disparities (NIMHD)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
National Eye Institute (NEI)

Assistance Listing Number(s)

93.307; 93.273; 93.279; 93.313; 93.867

Funding Opportunity Purpose

The purpose of this Funding Opportunity Announcement (FOA) is to encourage innovative health services research that can directly and demonstrably contribute to the improvement of minority health and/or the reduction of health disparities at the health care system-level as well as within clinical settings.

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

Specific Areas of Research Interest for NEI:

The mission of the National Eye Institute (www.nei.nih.gov) is to eliminate vision loss and improve quality of life through vision research. The NEI supports basic and clinical research into diseases and disorders of the visual system and the special needs of people with impaired vision or who are blind. NEI is particularly interested in eye- and vision-related health services research that can directly contribute to the improvement of minority health and the reduction of health disparities. This includes studies of strategies to improve health care access, delivery, utilization and quality, and health outcomes of people who are visually impaired or blind.

The National Eye Institute will not support clinical trials that are greater than minimal risk on this funding opportunity. Minimal risk is defined as the probability and magnitude of harm or discomfort anticipated in the research are not greater in and of themselves than those ordinarily encountered in daily life or during the performance of routine physical or psychological examinations or tests.

Section VII. Agency Contacts

Scientific/Research Contact(s)

Jimmy Le,Sc.D.
National Eye Institute (NEI)
Telephone: 301-435-8160
Email: [email protected]

Financial/Grants Management Contact(s)

Karen Robinson Smith
National Eye Institute (NEI)
Telephone: 301-435-8178
Email: [email protected]

All other aspects of the FOA remain the same.

Inquiries

Please direct all inquiries to:

Jimmy Le, Sc.D.
National Eye Institute (NEI)
Telephone: 301-435-8160
Email: [email protected]